ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Pneumonia
Virus Diseases
Human Influenza
Respiratory Tract Infections

COVID-19 trials near Seattle, WA, USA:

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...

Enrolling
COVID-19 Infection
Drug: remdesivir
Drug: placebo for ibuzatrelvir

Phase 3

Pfizer
Pfizer

Seattle, Washington, United States and 157 other locations

This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of it-...

Enrolling
Influenza, Human+COVID-19
Biological: Licensed COVID-19 Vaccine
Biological: Investigational mRNA Seasonal Flu/COVID-19 Combination (Flu/COVm) Vaccine

Phase 1

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Seattle, Washington, United States and 11 other locations

This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...

Active, not recruiting
COVID-19
Sars-CoV-2 Infection
Biological: NVX-CoV2705
Biological: Placebo

Phase 4

Novavax
Novavax

Seattle, Washington, United States and 98 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Seattle, Washington, United States and 28 other locations

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Redmond, Washington, United States of America and 226 other locations

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...

Active, not recruiting
COVID-19
SARS-COV-2 Infection
Biological: Placebo
Biological: BNT162b2 Vaccine

Phase 3

BioNTech
BioNTech

Redmond, Washington, United States of America and 198 other locations

This phase IIb trial compares the effect of LUNAR-COV19 vaccine to Comirnaty vaccine in treating adult patients who have received a hematopoietic cel...

Begins enrollment in 1 month
Hematopoietic and Lymphatic System Neoplasm
Biological: SARS-CoV-2 mRNA Vaccine ARCT-021
Biological: Tozinameran

Phase 2

Fred Hutchinson Cancer Center (FHCC)
Fred Hutchinson Cancer Center (FHCC)

Seattle, Washington, United States

This study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.

Not yet enrolling
SARS-CoV-2
Biological: mRNA-1273
Biological: mRNA-1283

Phase 2

Moderna
Moderna

Seattle, Washington, United States and 30 other locations

the chances of contracting coronavirus disease 2019 (COVID-19) or developing a severe form of COVID-19 disease i...

Active, not recruiting
COVID-19 Infection
Plasma Cell Myeloma
Biological: COVID-19 Vaccine
Other: Diagnostic Laboratory Biomarker Analysis

Phase 2

GeoVax

Seattle, Washington, United States and 5 other locations

) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...

Active, not recruiting
Relapsing Multiple Sclerosis
Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)
Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis
Novartis

Kirkland, Washington, United States and 299 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems